T1	NumberOfSamples 336 338	40
T2	Disease 18 31	breast cancer
T3	OrganismPart 18 24	breast
T4	Label 3692 3749	Stable Isotope Labelling with Amino Acids in Cell Culture
T5	Label 3762 3767	SILAC
*	Equiv T4 T5
T6	FactorValue 339 376;412 425	oestrogen receptor positive (luminal) breast tumour
T7	FactorValue 378 391;412 425	Her2 positive breast tumour
T8	FactorValue 396 425	triple negative breast tumour
T9	IonizationType 35660 35677	nano-electrospray
T10	Instrument 35694 35722	Q Exactive mass spectrometer
T11	FragmentationMethod 35872 35910	Higher energy collisional dissociation
T12	Modification 36407 36427	methionine oxidation
A1	Modification T12 variable
T13	Modification 36432 36454	N-terminal acetylation
A2	Modification T13 variable
T14	Modification 36486 36510	carbamidomethyl cysteine
A3	Modification T14 fixed
T15	SupplementaryFile 31372 31393	Supplementary Table 1
T16	AlkylationReagent 34212 34225	iodoacetamide
T17	CleavageAgent 34307 34314	trypsin
T18	NumberOfFractions 34659 34662	six
T19	FractionationMethod 34676 34712	strong anion exchange chromatography
T20	Separation 35549 35608	EASY-nLC nano high performance liquid chromatography system
T21	PrecursorMassTolerance 36607 36608;36612 36618	6 p.p.m.
T22	FragmentMassTolerance 36609 36618	20 p.p.m.
T23	Organism 36347 36352	Human
T24	NumberOfBiologicalReplicates 31336 31338	14
T25	NumberOfBiologicalReplicates 31353 31355	15
T26	NumberOfBiologicalReplicates 31365 31367	11
T27	EnrichmentMethod 31493 31516;31522 31570;31626 31661	highly cellular regions selected based on hematoxylin and eosin staining punched out from the paraffin block
